Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1

Listen to CLL experts Jeff Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from live CCO Webinars on optimizing BTK inhibitor therapy for patients with chronic lymphocytic leukemia (CLL).